facebook
twitter
rss
account
search
search
 

Canada mandates relabeling of kids' drugs

Dec. 18, 2008 at 3:53 PM   |   Comments

OTTAWA, Dec. 18 (UPI) -- Health Canada says it will require relabeling of all over-the-counter cough and cold medicines sold in Canada for use in children under the age of 12.

Officials said the new labels must indicate the medications should not be used in children under 6 years old. The products affected are those containing any active ingredients that are given orally:

--Antihistamines: brompheniramine maleate, chlorpheniramine maleate, clemastine hydrogen fumerate, dexbrompheniramine maleate, diphenhydramine hydrochloride, doxylamine succinate, pheniramine maleate, phenyltoloxamine citrate, promethazine hydrochloride, pyrilamine maleate and triprolidine hydrochloride.

--Antitussives: dextromethorphan, dextromethorphan hydrobromide or diphenhydramine hydrochloride.

--Expectorants: guaifenesin (glyceryl guaiacolate).

--Decongestants: ephedrine hydrochloride/sulphate, phenylephrine hydrochloride/sulphate or pseudoephedrine hydrochloride/sulphate.

Health Canada said the relabeling of the medications will be completed by next fall.

© 2008 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Most Popular
1
Say goodbye to Chinese sturgeon Say goodbye to Chinese sturgeon
2
Video shows scientists dissecting colossal squid Video shows scientists dissecting colossal squid
3
Attic window offers glimpse of life inside a wasp nest Attic window offers glimpse of life inside a wasp nest
4
First 3D-printed car unveiled in Chicago First 3D-printed car unveiled in Chicago
5
Impact that doomed dinos enabled spread of modern forests Impact that doomed dinos enabled spread of modern forests
Trending News
Video
x
Feedback